Doctor Yoriyasu Suzuki
Nagoya Heart Center, Nagoya (Japan)
Efficacy of tolvaptan in treating patients with heart failure with the preserved ejection fraction
Event: Acute Cardiovascular Care 2019
Topic: Pharmacotherapy
Session: Acute Heart Failure: Pharmacotherapy
Efficacy of Tolvaptan for the first hospitalized patients with acute decompensated heart failure
Event: Heart Failure 2018
Topic: Pharmacotherapy
Session: Acute Heart Failure– Treatment
Prevalence and clinical impact of tissue protrusion after stent implantation for acute coronary syndrome
Event: ESC Congress 2017
Topic: PCI: primary PCI / patient subsets
Session: Primary and acute PCI
The difference of benefit of tolvaptan for acute decompensated heart failure within different etiologies
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Acute heart failure (therapy)
Session: Acute heart failure
